ICON Newswire
Comprehensive Real-Time News Feed for ICON.
Results 1 - 20 of 71 in ICON
-
Venn Life Sciences Announces Management Changes
... held the position of Global Vice President of Business Development - DOCS, the strategic resourcing division of ICON plc. It was also announced today that Ms. GraciA lle Schutjens, who joined Venn in 2010, has been promoted to the position of Vice ... Comment?
-
Venn Life Sciences Announces Management Changes
... held the position of Global Vice President of Business Development - DOCS, the strategic resourcing division of ICON plc. It was also announced today that Ms. GraciA lle Schutjens, who joined Venn in 2010, has been promoted to the position of Vice ... Comment?
-
Zacks Investment Research Analysts Upgrade ICON plc Shares to "Neutral"
ICON plc was upgraded by Zacks Investment Research from an "underperform" rating to a "neutral" rating in a research note issued to investors on Thursday. Comment?
-
Taking Advantage of Europe's Pain
... So as those standards catch up, that is a lot of tailwind in their top line and bottom line. Another company I like is ICON Pharmaceuticals ( ICLR ). It's actually based in Ireland. I think it's gotten a little bit of a stigmatized buy down, but ... Comment?
-
VirtualScopics, PPD Expand Ties - Analyst Blog
... measurement of anatomical structures and metabolic activity. VirtualScopics competes with BioClinica Inc ( BIOC ) and ICON plc ( ICLR ), among others. The company remains committed to investing in infrastructure, services and additional technical ... Comment?
-
ICON Strengthens Global Scientific Council With the Appointments of and
Dublin, Ireland, January 24, 2012 - ICON plc , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Professor Brendan Buckley and Dr. Comment?
-
ICON Selected by Pfizer as a Global Strategic Partner for Clinical Research and Development
Icon plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced a strategic partnership with Pfizer Inc. Comment?
-
ICON Selected by Shire as Global Strategic Partner for Clinical...
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries, announced that is has signed a strategic partnership with Shire Specialty Pharmaceuticals to serve as the sole global provider of central laboratory services and one of two strategic partners for clinical development ... (more) Comment?
-
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. Comment?
-
ICON Selected by Shire as Global Strategic Partner for Clinical...
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries, announced that is has signed a strategic partnership with Shire Specialty Pharmaceuticals to serve as the sole global provider of central laboratory services and one of two strategic partners for clinical development ... (more) Comment?
-
Shire Selects ICON as Global Strategic Partner
ICON has signed a strategic partnership with Shire Specialty Pharmaceuticals to serve as the sole global provider of central lab services and one of two strategic partners for clinical development services. Comment?
-
Shire, ICON sign strategic partnership agreement
ICON plc, , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that is has signed a strategic partnership with Shire Specialty Pharmaceuticals to serve as the sole global provider of central laboratory services and one of two strategic partners for clinical ... (more) Comment?
-
ICON plc UK Regulatory Announcement: Re Alliance
"We are proud that Shire Specialty Pharmaceuticals has selected ICON as a global partner and it is yet another endorsement of ICON's expertise in operating under strategic partnership models" ICON Selected by Shire plc's Specialty Pharmaceuticals division as Global Strategic Partner for Clinical Research and Central Laboratory Services Dublin, ... (more) Comment?
-
ICON Selected by Shire plc's Specialty Pharmaceuticals division as...
ICON plc, , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that is has signed a strategic partnership with Shire Specialty Pharmaceuticals to serve as the sole global provider of central laboratory services and one of two strategic partners for clinical ... (more) Comment?
-
United Drug's Ronnie Kells to retire
... of the company since 2004 will succeed Mr Kells as Chairman. Mr. Gray is Vice Chairman and former Chief Executive of ICON plc and is also a Non-Executive Director of Danica Life Limited. Liam FitzGerald, Chief Executive, said: "Ronnie has been an ... Comment?
-
ICON Announces To Retire From Board of Directors
(BUSINESS WIRE)--ICON plc., (NASDAQ:ICLR)(ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the retirement of Non-Executive Director, Dr. ... Comment?
-
ICON plc UK Regulatory Announcement: ICON Announces Dr. Anthony...
"I would like to express the Board's thanks and appreciation for Tony's advice and support during his time on the Board and to convey the Board's best wishes to him for the future" ICON plc., , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the retirement of ... (more) Comment?
-
... The deal has been approved by Westmoreland's board. The transaction is likely to close by the end of January. Shares of ICON plc (NASDAQ: ICLR ) fell about 0.5% after the company announced the retirement of Non-Executive Director, Dr. Anthony Murphy ... Comment?
-
ICON Announces Dr. Anthony Murphy To Retire From Board of Directors
Anthony Murphy to become effective on 31st December 2011. "I would like to express the Board's thanks and appreciation for Tony's advice and support during his time on the Board and to convey the Board's best wishes to him for the future" Commenting on the announcement, ICON plc. Comment?
-
Simcere, BMS Add Cardiovascular Drug To Partnership
... the clinical applications of bone marrow stem cells, intercord mesenchymal stem cells and other human stem cells. ICON plc (NSDQ: ICLR ), a global CRO based in Ireland, made good on a promise to increase its China presence by acquiring a China ... Comment?
Most Popular
- Whitney Houston dead at 48 - 261 comments
- Father Shoots Laptop Over "Disrespectful" Facebook Post - 201 comments
- Catholic Bishops Group Denounces Contraception Compromise - 206 comments
- Religion And Birth Control: Not Just a Gop Fight - 240 comments
- Argentina to state Falklands case - 323 comments
- Whitney Houston, dead at 48, a crucial member of New Jersey's music scene - 136 comments
- 1.689 WNI ditolak masuk Singapura - 75 comments
- Church's 'Gay is not okay' sign gets backlash in social media - 94 comments
- Man Attacks Pub With Chain Saw - 111 comments
- Searcy Bank VP Indicted for Possession of Child Porn Had a Connection to Kevi... - 50 comments
Copyright ©2012 Topix LLC
